Send Email
Send SMS
Search
Million Health Pharmaceuticals
Million Health Pharmaceuticals


Velpatasvir

Prominent & Leading Manufacturer from Chennai, we offer velpanat, velpatasvir natco, myhep all, velasof velpatasvir tablets, velasof tablets and velasof medicines.

Velpanat

REQUEST CALLBACK

Velpanat
Approx. Rs 14,000 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
Packaging Size28 Tabs
Packaging TypeBottle
Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
UsageClinical, Hospital, Personal

Velpanat  is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Yes! I am interested

Velpatasvir Natco

REQUEST CALLBACK

Velpatasvir Natco
Approx. Rs 14,000 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
Strength/Dose (in mg or ml)Sofosbuvir 400mg & Velpatasvir 100mg
Pack Size28 Tablets in a bottle
Product TypeFinish Product
BrandVelpanat

Velpanat  is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Yes! I am interested

Velpanat

REQUEST CALLBACK

Velpanat
Approx. Rs 14,000 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
Packaging Size28 Tablets in a bottle
Packaging TypeBottle
Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
UsageClinical, Hospital, Personal

Velpanat  is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Yes! I am interested

Myhep ALL

REQUEST CALLBACK

Myhep ALL
Approx. Rs 13,500 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
Strength/Dose (in mg or ml)Sofosbuvir 400mg & Velpatasvir 100mg
Pack Size28 Tablets in a bottle
Product TypeFinish Product
BrandVelasof

Indication:

Myhep ALL is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Myhep ALL is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Myhep ALL exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Myhep ALL for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): Myhep ALL.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite
Yes! I am interested

Velasof Velpatasvir Tablets

REQUEST CALLBACK

Velasof Velpatasvir Tablets
Approx. Rs 14,500 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
BrandVelasof

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velasof Tablets

REQUEST CALLBACK

Velasof Tablets
Approx. Rs 15,000 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
Packaging Size28 Tablets
Packaging TypeBottle
Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
UsageClinical, Hospital, Personal

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velasof Medicines

REQUEST CALLBACK

Velasof Medicines
Approx. Rs 16,000 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
BrandVelasof

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velasof

REQUEST CALLBACK

Velasof
Approx. Rs 15,700 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
BrandVelasof

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velpatasvir Medicine

REQUEST CALLBACK

Velpatasvir Medicine
Approx. Rs 15,500 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
BrandVelasof

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velpatasvir Tablets

REQUEST CALLBACK

Velpatasvir Tablets
Approx. Rs 15,500 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
Packaging Size28 Tabs
Packaging TypeBottle
Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
UsageClinical, Hospital, Personal

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velpatasvir Medicine

REQUEST CALLBACK

Velpatasvir Medicine
Approx. Rs 14,000 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
BrandVelasof

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velpatasvir

REQUEST CALLBACK

Velpatasvir
Approx. Rs 15,500 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
Packaging Size28 Tabs
Packaging TypeBottle
Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
UsageClinical, Hospital, Personal

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velasof Tablets

REQUEST CALLBACK

Velasof Tablets
Approx. Rs 15,100 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
BrandVelasof

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velasof Medicines

REQUEST CALLBACK

Velasof Medicines
Approx. Rs 14,300 / Bottle
Get Best Quote
Product Details:
Minimum Order Quantity3 Bottle
Packaging SizeBottle
Packaging Type28 Tabs
Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
UsageClinical, Hospital, Personal

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

Yes! I am interested

Velasof

REQUEST CALLBACK

Velasof
Approx. Rs 14,000 / Bottle
Get Best Quote

Indication:

Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

 

Dosage and Administration:

Take Velasof exactly as your healthcare provider tells you to.

  • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
  • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
  • plus weight-based ribavirin with food for 12 weeks
  • Weight-based ribavirin dose.
  • Less than 75 kg: 1000 mg/day PO divided BID
  • ≥75 kg: 1200 mg/day PO divided BID
  • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
  • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

 

  • Minimum Order Quantity: 3 Bottle
  • Yes! I am interested

    Hepcinat 400 mg Tablet

    REQUEST CALLBACK

    Hepcinat 400 mg Tablet
    Approx. Rs 9,000 / Bottle
    Get Best Quote
    Product Details:
    Dose/Strength (mg or ml)400mg
    Pack Size28 Tablets
    Pack TypeBottle

    Being the market leader in this domain, we have come up with an effective Hepcinat 400 mg Tablet Our offered tablets are processed using the best quality chemical compounds and progressive technology by our vendors’ professionals. Used for the treatment of Hepatitis C infections, these tablets are checked on different quality measures so as to ensure their quality. We provide these tablets in diversified packaging options at market leading prices.

    Specifications:

    • Brand Name: Hepcinat
    • Active Ingredients: Sofosbuvir
    • Manufacturer: Natco
    • Country of Origin: India
    • Intended Patient: Unisex


    Features:
    • Balanced composition
    • Safe to consume
    • Hygienically packed
     
    Yes! I am interested

    Sofosbuvir Tablet

    REQUEST CALLBACK

    Sofosbuvir Tablet
    Approx. Rs 8,900 / Bottle
    Get Best Quote
    Product Details:
    BrandSofosbuvir Brands

    A flourishing enterprise in this domain, engaged in presenting a wide range of Sofosbuvir Tablet. The provided tablet is prescribed to the patients suffering from some critical diseases. The use of the tablet changes according to the diseases. Consuming the tablet helps in eliminating health issues and enhancing the metabolism. It strengthens the artery muscles and normalizes the blood circulation system in the body. At our end, the medicine is processed using clinically approved formulated salt and advanced sciences.

    Features:

    • Accurate composition
    • Anti-allergic in nature
    • Fewer side effects
    Yes! I am interested

    Resof Total

    REQUEST CALLBACK

    Resof Total
    Approx. Rs 14,000 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity3 Bottle
    BrandResof Total

    Indication:

    Resof Total is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Resof Total is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    Take Resof Total exactly as your healthcare provider tells you to.

    • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Resof Total for 12 weeks.
    • Patients with decompensated cirrhosis (Child-Pugh B or C): Resof Total.
    • plus weight-based ribavirin with food for 12 weeks
    • Weight-based ribavirin dose.
    • Less than 75 kg: 1000 mg/day PO divided BID
    • ≥75 kg: 1200 mg/day PO divided BID
    • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
    • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

     

    Yes! I am interested

    Velasof Medicines

    REQUEST CALLBACK

    Velasof Medicines
    Approx. Rs 14,500 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity3 Bottle
    BrandVelasof

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    Take Velasof exactly as your healthcare provider tells you to.

    • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
    • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
    • plus weight-based ribavirin with food for 12 weeks
    • Weight-based ribavirin dose.
    • Less than 75 kg: 1000 mg/day PO divided BID
    • ≥75 kg: 1200 mg/day PO divided BID
    • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
    • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

     

    Yes! I am interested

    Velasof Velpatasvir Tablet

    REQUEST CALLBACK

    Velasof Velpatasvir Tablet
    Approx. Rs 15,000 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity3 Bottle
    BrandVelasof

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    Take Velasof exactly as your healthcare provider tells you to.

    • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
    • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
    • plus weight-based ribavirin with food for 12 weeks
    • Weight-based ribavirin dose.
    • Less than 75 kg: 1000 mg/day PO divided BID
    • ≥75 kg: 1200 mg/day PO divided BID
    • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
    • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

     

    Yes! I am interested

    Velpatasvir

    REQUEST CALLBACK

    Velpatasvir
    Approx. Rs 15,000 / Bottle
    Get Best Quote

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    Take Velasof exactly as your healthcare provider tells you to.

    • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
    • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
    • plus weight-based ribavirin with food for 12 weeks
    • Weight-based ribavirin dose.
    • Less than 75 kg: 1000 mg/day PO divided BID
    • ≥75 kg: 1200 mg/day PO divided BID
    • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
    • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

     

  • Minimum Order Quantity: 3 Bottle
  • Yes! I am interested

    Velasof

    REQUEST CALLBACK

    Velasof
    Approx. Rs 14,500 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity3 Bottle
    Strength/Dose (in mg or ml)Sofosbuvir 400mg & Velpatasvir 100mg
    Pack Size28 Tablets in a bottle
    Product TypeFinish Product
    BrandVelasof

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    Take Velasof exactly as your healthcare provider tells you to.

    • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
    • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
    • plus weight-based ribavirin with food for 12 weeks
    • Weight-based ribavirin dose.
    • Less than 75 kg: 1000 mg/day PO divided BID
    • ≥75 kg: 1200 mg/day PO divided BID
    • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
    • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

     

    Yes! I am interested

    Velpanat

    REQUEST CALLBACK

    Velpanat
    Approx. Rs 14,800 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity3 Bottle
    Packaging Size28 tablets in a bottle
    Packaging TypeBottle
    Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & velpatasvir 100mg
    UsageClinical, Hospital, Personal

    Indication:

    Velpanat is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velpanat is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    Take Velpanat exactly as your healthcare provider tells you to.

    • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velpanat for 12 weeks.
    • Patients with decompensated cirrhosis (Child-Pugh B or C): velpanat.
    • plus weight-based ribavirin with food for 12 weeks
    • Weight-based ribavirin dose.
    • Less than 75 kg: 1000 mg/day PO divided BID
    • ≥75 kg: 1200 mg/day PO divided BID
    • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
    • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

     

    Yes! I am interested

    Velasof

    REQUEST CALLBACK

    Velasof
    Approx. Rs 14,500 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity3 Bottle
    Strength/Dose (in mg or ml)Sofosbuvir 400mg & Velpatasvir 100mg
    Pack Size28 Tablets in a bottle
    Product TypeFinish Product
    BrandVelasof

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    Take Velasof exactly as your healthcare provider tells you to.

    • Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): velasof for 12 weeks.
    • Patients with decompensated cirrhosis (Child-Pugh B or C): velasof.
    • plus weight-based ribavirin with food for 12 weeks
    • Weight-based ribavirin dose.
    • Less than 75 kg: 1000 mg/day PO divided BID
    • ≥75 kg: 1200 mg/day PO divided BID
    • Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance
    • Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

     

    Yes! I am interested

    Resof Total

    REQUEST CALLBACK

    Resof Total
    Approx. Rs 14,500 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity3 Bottle
    BrandResof Total

    Indication:

    Sofosbuvir With Velpatasvir is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection.

    Dosage and Administration:

    Sofosbuvir With Velpatasvir is available as a coformulated, once-daily single-pill combination of sofosbuvir 400 mg and velpatasvir 100 mg. The recommended dose is one tablet once daily, taken with or without food.

     

    • Renal Impairment: For patients with mild to moderate renal impairment, no dosage adjustment of sofosbuvir-velpatasvir is recommended. There are insufficient data regarding the safety and efficacy of sofosbuvir-velpatasvir in patients with severe renal impairment (eGFR less than 30 ml/min/1.73m2) or end-stage renal disease requiring hemodialysis. Accordingly, no dosage recommendation has been given for patients with severe renal impairment or end-stage renal disease requiring dialysis.
    • Hepatic Impairment: For patients with mild, moderate, or severe hepatic impairment (Child-Pugh Class A, B, or C), no dosage adjustment for sofosbuvir-velpatasvir is recommended. For patients with decompensated cirrhosis who are receiving sofosbuvir-velpatasvir and ribavirin, clinical and laboratory monitoring is recommended.
    Yes! I am interested

    Myhep ALL

    REQUEST CALLBACK

    Myhep ALL
    Approx. Rs 14,000 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Packaging Size28 tablets in a bottle
    Packaging Type28 tablets in a bottle
    Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
    UsageClinical, Hospital, Personal

    Indication:

    Myhep ALL is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Myhep ALL is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Myhep ALL exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Myhep ALL for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Myhep ALL.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Velpanat

    REQUEST CALLBACK

    Velpanat
    Approx. Rs 14,500 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Packaging Size28 Tablets in a bottle
    Packaging TypeBottle
    Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
    UsageClinical, Hospital, Personal

    Indication:

    Velpanat is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velpanat  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Velpanat exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velpanat for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Velpanat.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Resof Total

    REQUEST CALLBACK

    Resof Total
    Approx. Rs 14,000 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    BrandResof Total

    Indication:

    Resof Total is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Resof Total  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Resof Total exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Resof Total for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Resof Total.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Velasof Tablets

    REQUEST CALLBACK

    Velasof Tablets
    Approx. Rs 14,500 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    BrandVelasof

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Velasof exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velasof for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Velasof.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Velpanat

    REQUEST CALLBACK

    Velpanat
    Approx. Rs 14,300 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Packaging Size28 Tablets in a bottle
    Packaging TypeBottle
    Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
    UsageClinical, Hospital, Personal

    Indication:

    Velpanat is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velpanat  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Velpanat exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velpanat for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Velpanat.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Velasof

    REQUEST CALLBACK

    Velasof
    Approx. Rs 14,700 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Strength/Dose (in mg or ml)Sofosbuvir 400mg & Velpatasvir 100mg
    Pack Size28 Tablets in a bottle
    Product TypeFinish Product
    BrandVelasof

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Velasof exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velasof for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Velasof.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Myhep ALL

    REQUEST CALLBACK

    Myhep ALL
    Approx. Rs 14,000 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Packaging Size28 Tablets in a bottle
    Packaging Type28 Tablets in a bottle
    Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
    UsageClinical, Hospital, Personal

    Indication:

    Myhep ALL is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Myhep ALL is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Myhep ALL exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Myhep ALL for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Myhep ALL.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Resof Total

    REQUEST CALLBACK

    Resof Total
    Approx. Rs 14,200 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    BrandResof Total

    Indication:

    Resof Total is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Resof Total  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Resof Total exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Resof Total for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Resof Total.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Velpanat

    REQUEST CALLBACK

    Velpanat
    Approx. Rs 14,500 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Packaging Size28 Tablets in a bottle
    Packaging TypeBottle
    Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & velpatasvir 100mg
    UsageClinical, Hospital, Personal

    Indication:

    Velpanat is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velpanat  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Velpanat exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velpanat for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Velpanat.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Velasof Tablets

    REQUEST CALLBACK

    Velasof Tablets
    Approx. Rs 14,700 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    BrandVelasof

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Velasof exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velasof for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Velasof.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Resof Total

    REQUEST CALLBACK

    Resof Total
    Approx. Rs 14,000 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    BrandResof Total

    Indication:

    Resof Total is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Resof Total  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Resof Total exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Resof Total for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Resof Total.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Myhep ALL Tablets

    REQUEST CALLBACK

    Myhep ALL Tablets
    Approx. Rs 14,350 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Packaging Size28 Tablets in a bottle
    Packaging TypeBottle
    Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
    UsageClinical, Hospital, Personal

    Indication:

    Myhep ALL is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Myhep ALL is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Myhep ALL exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Myhep ALL for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Myhep ALL.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Velpanat Tablets

    REQUEST CALLBACK

    Velpanat Tablets
    Approx. Rs 14,700 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Packaging Size28 Tablets in a bottle
    Packaging TypeBottle
    Dose/Strength (ex. 1 mg or 1 ml)Sofosbuvir 400mg & Velpatasvir 100mg
    UsageClinical, Hospital, Personal

    Indication:

    Velpanat is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velpanat  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Velpanat exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velpanat for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Velpanat.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Velasof Medicines

    REQUEST CALLBACK

    Velasof Medicines
    Approx. Rs 14,900 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    Dose/Strength (mg or ml)Sofosbuvir 400mg & velpatasvir 100mg
    Pack TypeBottle

    Indication:

    Velasof is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Velasof  is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Velasof exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Velasof for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Velasof.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

    Myhep ALL Medicines

    REQUEST CALLBACK

    Myhep ALL Medicines
    Approx. Rs 14,500 / Bottle
    Get Best Quote
    Product Details:
    Minimum Order Quantity1 Bottle
    BrandMyhep All

    Indication:

    Myhep ALL is an combination of velpatasvir 100mg+ Sofosbuvir 400mg. Myhep ALL is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir,a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection with pangenotypic activity.

     

    Dosage and Administration:

    ·        Take Myhep ALL exactly as your healthcare provider tells you to.

    ·        Patients without cirrhosis or with compensated cirrhosis (Child-Pugh A): Myhep ALL for 12 weeks.

    ·        Patients with decompensated cirrhosis (Child-Pugh B or C): Myhep ALL.

    ·        plus weight-based ribavirin with food for 12 weeks

    ·        Weight-based ribavirin dose.

    ·        Less than 75 kg: 1000 mg/day PO divided BID

    ·        ≥75 kg: 1200 mg/day PO divided BID

    ·        Ribavirin starting dose and on-treatment dosage should be modified based on hemoglobin and creatinine clearance

    ·        Dose modification:Severe renal impairment (eGFR less than 30mL/min/1.73 m²) or ESRD: No dosage recommendation can be give owing to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite

    Yes! I am interested

     
    X


    Call Us: +91-8046030479
    Million Health Pharmaceuticals
    R. Saravanan (Proprietor)
    Portion A, First Floor, Old No. 131, New No. 50, Pedariyar Koil Street, Seven Wells ,
    Chennai - 600001, Tamil Nadu, India
    Contact via E-mail
    Contact via SMS


    Home  |   About Us   |  Our Product Range  |  Site Map  |   Contact Us   |   Mobile Site

    © Million Health Pharmaceuticals. All Rights Reserved (Terms of Use)
    Developed and Managed by IndiaMART InterMESH Limited

    Million Health Pharmaceuticals